-- Query Results

McElhatton, P. R., Bateman, D. N., Evans, C., Pughe, K. R., & Thomas, S. H. L. (1999). Congenital anomalies after prenatal ecstasy exposure. The Lancet, 354(9188; 23.10.1999), 1441–1442. Abstract: Prospective follow-up of 136 babies exposed to ecstasy in utero indicated that the drug may be associated with a significantly increased risk of congenital defects (15·4% [95% CI 8·2—25·4]). Cardiovascular anomalies (26 per 1000 livebirths [3·0—9·0]) and musculoskeletal anomalies (38 per 1000 [8·0—109·0]) were predominant. Keywords: health promotion; addiction; AOD dependence; chemical addiction; ecstasy https://refbases.infodrog.ch/show.php?record=59663

Abstract: Prospective follow-up of 136 babies exposed to ecstasy in utero indicated that the drug may be associated with a significantly increased risk of congenital defects (15·4% [95% CI 8·2—25·4]). Cardiovascular anomalies (26 per 1000 livebirths [3·0—9·0]) and musculoskeletal anomalies (38 per 1000 [8·0—109·0]) were predominant.

Keywords: health promotion; addiction; AOD dependence; chemical addiction; ecstasy

https://refbases.infodrog.ch/show.php?record=59663